Beta Drugs (India) Probability of Future Stock Price Finishing Under 2060.05
| BETA Stock | 2,060 66.95 3.15% |
Beta |
Beta Drugs Target Price Odds to finish below 2060.05
The tendency of Beta Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 2,060 | 90 days | 2,060 | about 70.3 |
Based on a normal probability distribution, the odds of Beta Drugs to move below current price in 90 days from now is about 70.3 (This Beta Drugs probability density function shows the probability of Beta Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Beta Drugs has a beta of 0.35 suggesting as returns on the market go up, Beta Drugs average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Beta Drugs will be expected to be much smaller as well. Additionally Beta Drugs has an alpha of 0.2211, implying that it can generate a 0.22 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Beta Drugs Price Density |
| Price |
Predictive Modules for Beta Drugs
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Beta Drugs. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Beta Drugs Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Beta Drugs is not an exception. The market had few large corrections towards the Beta Drugs' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Beta Drugs, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Beta Drugs within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.22 | |
β | Beta against Dow Jones | 0.35 | |
σ | Overall volatility | 213.54 | |
Ir | Information ratio | 0.07 |
Beta Drugs Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Beta Drugs for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Beta Drugs can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Beta Drugs had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Oncology-focused Beta Drugs raises Rs 117 crore from Healthquad, others - MSN |
Beta Drugs Technical Analysis
Beta Drugs' future price can be derived by breaking down and analyzing its technical indicators over time. Beta Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Beta Drugs. In general, you should focus on analyzing Beta Stock price patterns and their correlations with different microeconomic environments and drivers.
Beta Drugs Predictive Forecast Models
Beta Drugs' time-series forecasting models is one of many Beta Drugs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Beta Drugs' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Beta Drugs
Checking the ongoing alerts about Beta Drugs for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Beta Drugs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Beta Drugs had very high historical volatility over the last 90 days | |
| Latest headline from news.google.com: Oncology-focused Beta Drugs raises Rs 117 crore from Healthquad, others - MSN |
Additional Tools for Beta Stock Analysis
When running Beta Drugs' price analysis, check to measure Beta Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Drugs is operating at the current time. Most of Beta Drugs' value examination focuses on studying past and present price action to predict the probability of Beta Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Drugs' price. Additionally, you may evaluate how the addition of Beta Drugs to your portfolios can decrease your overall portfolio volatility.